Viscofan World You are in: The Viscofan Group EN | ES
Global

The Viscofan Group

EN | ES
Europe

Belgium

EN

Czech Republic

CS | EN

Germany

DE

Serbia

EN | SR

Spain

ES
Americas

Brazil

PT

Canada

EN | FR

Mexico

ES

United States

EN

Uruguay

ES
Asia & Oceania
Viscofan BioEngineering
The Viscofan Group has released its 1Q25 results
28/April/2025

Main conclusions of the January-March 2025 results:

• Revenue of €307.3 million, an increase of 6.1% compared to the previous year with growth in all geographic reporting areas. 

• EBITDA of €68.8 million, a growth of 11.7% on the previous year and with an improvement of +1.1 p.p. in EBITDA margin to 22.4%.

• Net profit of €31.4 million, -0.7% below the previous year impacted by the financial result of negative exchange rate differences.

• Net bank debt at March 2025 was €170.8 million (€146.9 million at December 2024) including a cash outflow of €23.5 million from the share buybacks carried out within the framework of the flexible remuneration program.

• José Antonio Canales, CEO of the Viscofan Group:

"The strength of our business model has been reflected again in the growth in revenue and in operating profit in the first quarter results. All geographic reporting areas grew year-on-year driven by volumes in the main casings families, the recovery in the New Business division, and even with higher revenue from co-generation in Spain.

Growth together with cost control, production efficiencies, and higher competitiveness in the quarter, where exchange rates variation had a positive impact on operating results. However, the US$ weakness eroded this growth in terms of Net profit, which decreased 0.7% year-on-year.

First quarter results in operating terms are in line with the objectives set for 2025, the year of consolidation of our Beyond25 strategic plan.”

All results information is available in the Investor Relations section of the website. LINK

® Viscofan Group